C-DETECT: Cancer Detection for Early Tumors using Enhanced Cell Targeting
Carnegie Mellon University in Pittsburgh, Penn., with its commercial partner Ginkgo Bioworks, aims to develop orally-administered probiotic sensors, which will release bespoke barcodes for urine-based detection with a custom chip.